According to Moderna
's latest financial reports the company has $12.81 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $13.85 B | -27.55% |
2022-12-31 | $19.12 B | 35.19% |
2021-12-31 | $14.14 B | 452.32% |
2020-12-31 | $2.56 B | 117.99% |
2019-12-31 | $1.17 B | -23.23% |
2018-12-31 | $1.53 B | 144.72% |
2017-12-31 | $0.62 B | -25.72% |
2016-12-31 | $0.84 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $70.02 B | 446.31% | ๐บ๐ธ USA |
Novartis NVS | $39.75 B | 210.18% | ๐จ๐ญ Switzerland |
Merck MRK | $37.63 B | 193.63% | ๐บ๐ธ USA |
Regulus Therapeutics RGLS | $21.18 M | -99.83% | ๐บ๐ธ USA |
Athersys ATHX | -$36.4 M | -100.28% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -$0.22 B | -101.71% | ๐บ๐ธ USA |
Arrowhead Pharmaceuticals
ARWR | $0.17 B | -98.64% | ๐บ๐ธ USA |